Melanoma breakthrough for Merck
April 26, 2013Research and Development, Sales and Marketing FDA, Merck, lambrolizumab, melanoma
Merck’s pipeline has been given a boost by an FDA decision to designate early-stage investigational drug lambrolizumab as a breakthrough …
Pharma R&D ‘untenable’
April 25, 2013Research and Development, Sales and Marketing GlobalData, R&D
The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …
Boehringer’s online PMCPA breach
April 25, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA
Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …
Navigating Cancer hires VP from InVentiv Health
April 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health, navigating cancer
Cancer support service company Navigating Cancer has appointed Suzanne Greenwood to the firm as vice president, Bio-Pharmaceutical Services. Greenwood has …
US doctors support self-monitoring patients
April 24, 2013Medical Communications, Sales and Marketing Manhattan research, doctors, taking the pulse
A new survey of US doctors has found that most have patients who are measuring their health data themselves, and …
£50m oncology fund pays out
April 24, 2013Research and Development, Sales and Marketing Cancer, ICR, MPS1
The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …
Roche restructures life science business
April 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts
Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …
The competitor room comes of age
April 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, competitor room
It was great to be back at SonoPharm, it was so still at this time of day and she went …
Specialist publisher acquires Pharmafile portfolio
April 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Samedan, Wiley, pharmafile
Samedan Ltd has extended its range of market-leading pharmaceutical magazines with the acquisition of the Pharmafile portfolio. The London-based firm …
NHS Trust appoints comms director
April 24, 2013Medical Communications, Sales and Marketing NHS Trust, Tiernan, comms
Antony Tiernan has joined West Hertfordshire Hospitals Trust as its director of corporate affairs and communications. Tiernan held this same …
HCV agreement for Merck and BMS
April 23, 2013Research and Development, Sales and Marketing BMS, HCV, Merck
Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …
AstraZeneca signs $200m nanomedicine deal
April 23, 2013Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine
AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …
Orexigen’s chief executive elected to PhRMA Board
April 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen
Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …
DSM plans July opening for Australian biopharma facility
April 23, 2013Manufacturing and Production CMO, DSM
Contract manufacturing organisation DSM Pharmaceutical Products is planning to officially open a new biopharma plant in Australia in July as …
J&J sees OTC recovery in Q1
April 23, 2013Manufacturing and Production J&J, JJ, manufacturing issues, recall
Johnson & Johnson is moving steadily closer to a sustained recovery in its McNeil Consumer Healthcare division as the manufacturing …
German regulator assesses more drugs
April 22, 2013Sales and Marketing AMNOG, Bayer, Germany, Pradaxa, Xarelto
A new raft of drugs which will be subject to potentially stringent cost/benefit analysis in Germany has been announced. The …
‘No consensus’ on transparency
April 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency
An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …
New appointments to advise ministers on proposed NHS changes
April 22, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, granger, reforms
The Department of Health has announced that five new members will join the Independent Reconfiguration Panel (IRP) from May. The …
Sanofi reinforces presence in Morocco
April 19, 2013Manufacturing and Production Morocco, Sanofi, emerging markets, logistics
Sanofi has opened a new logistics hub in Morocco to help it increase and accelerate distribution of its medicines throughout …
Jail for man in data trial
April 19, 2013Sales and Marketing MHRA, Scientist
A British scientist has become the first person to be jailed under the Good Laboratory Practice (GLP) Regulations 1999 for …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
